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In the absence of crystallographic data, :he roechambm of mtrogen transfer from glatalnin¢ in ahparagine synthetase (AS) remain~ under active 
investigation. Surprisingly, tl~¢ glutamme-dependent AS from E~chet tchta colt (AsnB) appears to lack a conserved histidme residue, necessary for 
mtrogea transfer if the reaction proceeds by the accepted pathway :n other glutamine amidotransferases, but retains the abdity to synthe.~lze 
asparasine. We propose an alternative n~echanisrn for nltrogen transfer m AsnB wh)ch obviates the reqmrement for participation of histtdme m 
this step. Our hypothesis may also be more generally applicable to other glutalaame-dependent amidotransferases. 
Asparaglne synthetase, Nltrogell transfer; Thiol pretense; Glatamine; Eschertchta colt 
1. INTRODUCTION 
Cancers which reside in organs uch as the liver utilize 
hepatic tissue as an asparagine reservoir [1], and the 
effectiveness of L-asparaginase therapy appears related 
to its ability to decrease circulating concentrations of
asparagine [2]. Such observations have led to the sug- 
gestion that potent, highly specific inhibitors of aspar- 
agine biosynthesis might be useful anti-neoplastic 
agents. A broad range of possible inhibitors, including 
,O-hydroxyaspartate derivatives [3] and aromatic sulfon- 
ylfluoride analogues of asparagine and glutamine [4]° 
have been screened for activity, both in vivo and in 
vitro, against asparagine synthetase (AS). In other 
work, over 700 compounds were assayed as AS irahib- 
itors, but all those found to inhibit AS exhibited only 
weak activity [5,6]. The failure of these previous at- 
tempts to develop otent AS inhibitors can probably be 
attributed to the lack of information concerning the 
chemical and structural details underlying the enzyme 
reaction mechanism, given that such knowledge ha~ led 
to striking success in the development of therapeutic 
agents for other biologically important classes of en- 
zymes [7]. In eukaryotes, AS catalyzes the following 
reactions [8]: 
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Gln+ H20 -> Glu ÷ NH (1) 
NH3 + Asp + ATP ~ Asn+ AMP + PP. (2) 
G i r l+Asp÷ ATP --~ Ash+ GIu+AMP+PP,  (3) 
Variants of AS have been purified from Novikoff 
hepatomas [9] and from RADAI murine leukemia cells 
resistant o L-asparaginase [10], and more recent work 
has resulted in the isolation of the gene for human AS 
[11], allowing the deternaination of the primary se- 
quence of the protein. Furthermore, characterization f 
the substrate specificity of human AS with respect o 
glutamine has proved possible using over-expressed n- 
zyme [12]. Asparagine synthetases have also been iso- 
lated from bacteria, e.g. Streptococcus bovi~' [13], Esch- 
erichia coil [ 14,15] and Lactobacillus arabinosus [ 16], the 
yeast Saccharornyces cerevisiae [17,18], and fungi, such 
as Neurospora crassa [19]. However, some of these spe- 
cies, including E. coli, have two unlinked genes tbr as- 
paragine synthesis, one of which (AsnA) encodes a pro- 
tein capable of catalyzing v:~iy the ammonia-dependent 
synthesis of asparagine while the other (AsnB) encodes 
an enzyme which can catalyze reactions 1-3. The AsnA 
gene product has been extensively characterized in 
terms of kinetics and mechanism [14,15], although the 
detailed kinetic order of binding and release remains 
controversial in the light of studies using asparagine 
synthetases prepared from different sources (human 
tumor, rat liver or beef pancreas) [20]. Significantly, 
experiments upon AsnA employing l~O-labelled aspar- 
tare have demonstrated the existence of an aspartyl- 
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AMP intermediate [15]. Building upon our purification 
and charactertzation f beef pancreaUc asparagme syn- 
thetase [21], we have sequenced the gene encoding as- 
paragine synthetase in E. coli (Fig. I) [22]. The three 
enzymes (human, E. coli AsnA and E. coti AsnB) have 
been sequenct:d, over-expressed and purified, which, in 
the case of human AS and E. cob AsnB, has allowed the 
detailed characterization f their substrate specificities 
and kinetic parameters for glutamine-dependent aspar- 
agine synthesis (Table 1) (unpublished results). Human 
AS is a member of the pufF family of glutamine-de- 
pendent amide transfer enzymes, which are character- 
ized by the presence of an N-terminal cysteine followed 
by conserved glycine and isoleucine residues [23]. Pri- 
Table 1 
Kinetic parameters determined for purilied hmnan AS and A~nB 
enzymes 
Enzyme K,,~ I/,~, k,, k,=t/K~ 
(mM) (nmol mg -~ mm -j) (s-') (M-' ~-J) 
Human AS 1.18 360.0 0.~o . . . . . .  .~-._ 
E, " - "  A .n  ,~ "~la O 0.75 . . . . . . s . . ,  O . . . . .  6,250 
K,n refem to glulamme oncentranon at saturating concenlrauons of
aspar~le acid and ATP. k,at is exprcs~ per subunit 
mary sequence alignment of purF-type enzymes has 
also identified conserved histidine and aspartie acid res- 
idues, which has led to the suggestion that a "catalytic 
triad' [24], reminiscent of that lbund in thiol proteases, 
su h as papain [25] and aetinidha [26], might be involved 
in the hydrolysis of 81atamine to yield glutamate and 
ammonia. However, our sequencing studies clearly 
showed that AsnB did not possess a residue correspond- 
ing to the conserved histidine in its glutamine ami- 
dotransferase (GAT) domain, in contrast o all other 
members of the purF lhmily [22]. That this result was 
not due to an error in ou; original sequencing protocol 
was confirmed by re-determining the gene sequence sev- 
eral ames using standard ideoxy techniques [27] (data 
not shown). On the other hand, even in the apparent 
absence of this histidine, the k=JK.,, values for the glu- 
tamine-dependent conversion of aspartie acid into as- 
paragine revealed that the bacterial enzyme was more 
efficient han human AS (Table I). Detailed analysis of 
the kinetic constants for these two enzymes hows that 
almost all of this difference can be attributed to tighter 
binding of glutamine by AsnB. Hence, the Kn~ for glu- 
tamine in human asparagine synthetase was 1.18 mM 
while that of AsnB was an order of magnitude smaller. 
More surprising, given the lack of the 'conserved' histid- 
ine, the V,,,~ values associated with the two proteins 
only differed by a factor of 2 (Table 1). These observa- 
tions indicate that, at least in the case of AsnB, the 
generally accepted meelmnism for nitrogen transfer in 
the glutamine-dependent sy thesis of asparagine, as de- 
duced from work on other members of the parF enzyme 
family [28], might not be operating. In this paper, we 
briefly review the current model for the role of the cat- 
alytic triad in transferring nitrogen from glutamine to 
aspartic acid, and propose an alternative catalytic 
mechanism which obviates the participation of a histi- 
dine residue in such a reaction. 
2. DISCUSSION 
In purF-type enzymes, most notably glutaraine 
phosphoribosylpyrophosphate amidotransferase (GPA) 
[29], the N-terminal eysteine residue appears implicated 
in the formation of a covalent ghttaminyl intermediate. 
That Cys-I is critical for glutamine-dependent, bu  not 
ammonia-dependent, synthesis of asparagine has been 
shown by covalent modification of this residue wRh 
DON [30], which results only in the elimim,.tion of glu- 
tamine-dependent ac ivity [23]. In independent s udies 
we have established that the Cys-1 --~ Ale and Cys-I ---+ 
Set mutants of human AS possess no glutaminase activ- 
ity [31]. In elegant studies upon the role of the catalytic 
triad in the nitrogen transfer eaction, mutagenesis of
both His-101 and Asp-29 in GPA resulted in the loss of 
• _ I - J - -~  r'~')a giutamine-, but not anamonm-U~laUnuuiit ac i'dty t--'l. 
In GPA, in analogy to thiol proteases [32], it was there- 
fore proposed that glutamine is converted into an 
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Fig. 2. (a) Currently accepted mechanmm for the hydrolysis of Blutamine to yield ammonia nd an acylenzyme I by analogy with the puff  enzyme, 
GPA [23]. (b) Synthesis of asparagine by reaction of ammonia with activated aspartyl deiivative 2. (c) Hydrolysis reaction to yield glutamate from 
the acylenzyme 1. Residue numberia~ corresponds to that of human AS [! I], 
acylenzyme derivative 1 (Fig. 2) by nucleophilic attack 
of the Cys-1 thiolatc anion upon the primary amide, 
which releases ammonia. Extending this analogy to 
human AS, asparagine would then be tbrmed by the 
reaction of ammonia with the activated AMP derivative 
of aspartic acid 2 (Fig. 2). His-102 could not only pro- 
mote the formation of the Cys-I thiolate anion but also 
be involved in catalyzing the hydrolysis of acylenzyme 
1, the reaction that is rate-determining  thiol proteases 
[33]. Given that human AS also contains the conserved 
residues defining the ea:a!ytic triad [! !], it has therefore 
been proposed, as one of several hypotheses, that hy. 
drolysis of glutamine to yield free ammonia is the basis 
of the glutamine-dependent activity in this enzyme [23]. 
100 
However, due to the lack of structural information con- 
cerning the location of the glutamine and ammonia 
binding pockets in human AS, evidence for the enzymic 
generation of 'free' ammonia s an intermediate in the 
nitrogen transfer eaction is, of necessity, circumstan- 
tial. On the other hand, it is true that all asparagine 
synthetases, and other purF enzymes, can utilize ammo- 
nia as a nitrogen source in the absence ofglutamine [24], 
showing that free ammonia can not only bind within the 
enzyme's active site, but remains sufficiently nucleo- 
philie to release asparagine from aspartyl-AMP. Ques- 
tions concerning the molecular mechanism by which 
ammonia is sequestered from solvents and retained in 
its unprotonated form also remain open. 
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Residue namberm~ corresponds to that of the AsnB 8¢ne product [22]. 
Our finding that the GAT domain of AsnB lacks the 
conserved histidine residue but still exhibits similar 
specificity to human AS indicates that, at least for this 
AS variant, formation of the acylenzyme inteLmediate 
may not occur by the proposed mechanism. Hence, we 
have become intrigued by alternative chemical path- 
ways lbr the nitrogen transfer eaction which do not 
necessarily obligate the generation of free ammonia. 
One such mechanism, against which there is currently 
no evidence, involves reaction of the primary amide of 
glutamine as a nucleophile in the presence of the acti- 
vated aspartate-AMP derivative, which implies that the 
key intermediate in the nitrogen transfer step would be 
the unsymmetrical imide 3 (Fig. 3). We note that the 
biosynthetic pathway leading to N.glycosylated pro- 
teins provides triking evidence that, under the correct 
conditions, nucleophilic attack by primary amides can 
be observed in biological systems [34]. Further, albeit 
indirect, evidence lbr this proposal is provided by the 
reactivity of certain glutamine derivatives used in solid- 
phase peptide synthesis, in which the side chain amide 
is unprotected [35]. Such compounds generally ield 
peptide mixtures due to coupling at both the C=-¢ar- 
boxyl and the side chain carbonyl groups, which can be 
rationalized as arising from the formation of cyclic ira- 
ides as reaction intermediates. For example, the acti- 
vated glutamine 4 (Eqn. l) undergoes facile cyclizafion 
although the ester is almost certainly less reactive than 
an acylated AMP derivative [36]. 
0 
t4 I ~NH= 
t ~UO2CHN'~ I ~, 
0 
4 
~ 0 ~ OuO~CHN H 
0 
Equauon I. 
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A notable feature of this hypothesis is that Cys-I 
would still be essential for glutamine-dependent ~activity 
since the hydrolysis of imide 3 must still occur in the 
formation of asparagine. The need for a separate bind- 
ing pocket for ammonia is also eliminated by formation 
of the imide as 3 could interact with the protein through 
the same functional groups used in binding glutamine 
and aspartate. An interesting chemical feature of 3 is 
that the nitrogen retains amide character and so pos- 
sesses little basicity. In addition, the leaving group in the 
hydrolysis step becomes the anionic form of asparagine, 
relaxing the requirement for general acid catalysis by an 
adjacent histidine residue. Hence, this reaction mecha- 
nism does not necessitate an active site histidine, except 
possibly as a means of stabilizing the thiolate anion. 
Should there prove to be a close analogy between the 
hydrolysis reaction in the GAT-domain of asparagine 
synthetases and thiol pretenses, then breakdown of the 
acylenzyme should be th.e rate-limiting step in the amide 
nitrogen transfer reaction. In the case of papain, the 
archetypal thiol protease [37] and for which an X-ray 
crystal structure is available [38], while the consensus of 
opinion favors catalysis of acylenzyme hydrolysis by 
His- 159, the possibility that Asp-158 can act as a gen- 
eral base catalyst has not been unequivocally ruled out 
[39]. Therefore, in the AsnB enzyme, Asp-33 rnay be 
involved in catalyzing the breakdown of an acylenzyme 
to release glutamate. Finally, the utilization of imide 3 
as a reaction intermediate liminates the possibility of 
diffusion of ammonia from the active site during nitro- 
gen transfer, and obviates the need for additional pro- 
rein functionality so as to maintain intermediates, uch 
as ammonia, in their unprotonated state. 
We are presently undertaking the synthesis of lhe 
unsymmetrical imide 3 in order to evaluate whether this 
compound is an authentic intermediate in the nitrogen 
transfer reaction. Whatever the outcome of our experi- 
~,ents, it is clear that significant questions remain COla- 
eerning the functional role of conserved residues in the 
GAT domains of AS and other amidotransferases. 
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